Search - tctmd.com

Displaying 161 - 180 of 589

Sort: Relevancy | Date

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Caitlin E. Cox

August 04, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

Advertisement

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

CV Care Around Noncardiac Surgery: New ESC Guidelines

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Polypill Bests Usual Care in Patients With Recent MI: SECURE

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

What’s Going to Be Hot at ESC 2022?

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Certain CV Meds Tied to Higher MI Risk in Warmer Weather

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content